ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 23 filers reported holding ANI PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,476,000 | -34.5% | 1,340,000 | -40.2% | 0.01% | -33.3% |
| Q4 2018 | $2,252,000 | -10.0% | 2,242,000 | -5.1% | 0.02% | +12.5% |
| Q3 2018 | $2,502,000 | -39.7% | 2,363,000 | -33.7% | 0.02% | -15.8% |
| Q4 2017 | $4,146,000 | +47.3% | 3,564,000 | +37.6% | 0.02% | 0.0% |
| Q3 2017 | $2,815,000 | -54.3% | 2,591,000 | -55.6% | 0.02% | -53.7% |
| Q2 2017 | $6,159,000 | +233.5% | 5,837,000 | +234.5% | 0.04% | +192.9% |
| Q1 2017 | $1,847,000 | +8295.5% | 1,745,000 | +8625.0% | 0.01% | – |
| Q2 2016 | $22,000 | +22.2% | 20,000 | 0.0% | 0.00% | – |
| Q1 2016 | $18,000 | -96.2% | 20,000 | -96.1% | 0.00% | -100.0% |
| Q3 2015 | $475,000 | – | 516,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 59,455 | $68,522,000 | 3.54% |
| DLD Asset Management, LP | 4,500,000 | $5,185,000 | 1.70% |
| Worth Venture Partners, LLC | 945,000 | $1,100,000 | 1.18% |
| Perceptive Advisors | 7,500,000 | $8,700,000 | 0.62% |
| WOLVERINE ASSET MANAGEMENT LLC | 15,439,000 | $17,789,000 | 0.23% |
| Allianz Asset Management GmbH | 35,165,000 | $40,795,000 | 0.04% |
| GABELLI FUNDS LLC | 1,500,000 | $1,740,000 | 0.01% |
| AQR Arbitrage LLC | 525,000 | $605,000 | 0.01% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 9,000,000 | $10,328,000 | 0.01% |
| Edge Advisors, LLC | 33,000 | $38,000 | 0.01% |